Fund shareholders of Amicus Therapeutics Inc
ISIN US03152W1099 · United States · LEI 549300MRD1SMUTNBPQ53
- Fund shareholders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- ≈ 1.6M $ 14.8M SEK
- Share of capital
- 0.0 % of 314M shares on Feb 12, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
3 funds hold this company. This table lists the 1 that declare it in a regulatory filing. The other 2 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 107,541 | 14.8M SEK | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.41 % | as of Sep 30, 2025 ↗ |
| Carmignac Portfolio Merger Arbitrage Plus Carmignac Gestion Luxembourg S.A. | 1.00 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.41 % | as of Sep 30, 2025 ↗ |
| Carmignac Portfolio Merger Arbitrage Plus Carmignac Gestion Luxembourg S.A. | 1.00 % | as of Dec 31, 2025 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 0.05 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 149 | -54 | 69,996,806 | -15.4 % |
| 2026Q1 | 203 | -29 | 82,722,046 | -23.0 % |
| 2025Q4 | 232 | +9 | 107,454,496 | -1.7 % |
| 2025Q3 | 223 | -22 | 109,272,588 | -4.3 % |
| 2025Q2 | 245 | +8 | 114,134,159 | -1.7 % |
| 2025Q1 | 237 | -10 | 116,106,325 | -6.5 % |
| 2024Q4 | 247 | +11 | 124,208,473 | -0.2 % |
| 2024Q3 | 236 | -21 | 124,491,722 | +1.3 % |
| 2024Q2 | 257 | +9 | 122,889,493 | +15.4 % |
| 2024Q1 | 248 | +8 | 106,490,189 | +2.5 % |
| 2023Q4 | 240 | 103,936,942 |
Institutional managers
289 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 33,879,048 | 489.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 15,957,913 | 230.8M $ | as of Mar 31, 2026 |
| Pentwater Capital Management LP | 14,000,000 | 202.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 12,893,897 | 186.4M $ | as of Mar 31, 2026 |
| GLAZER CAPITAL, LLC | 12,722,749 | 184K $ | as of Mar 31, 2026 |
| FIL Ltd | 12,560,028 | 181.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 11,556,008 | 167.1M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 8,809,340 | 127.4M $ | as of Mar 31, 2026 |
| HBK INVESTMENTS L P | 8,783,448 | 127M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 8,535,918 | 123.5M $ | as of Mar 31, 2026 |
| O'Connor Alternative Investments LLC | 8,444,992 | 122.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 7,908,459 | 114.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 6,998,884 | 101.2M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,749,190 | 97.4M $ | as of Mar 31, 2026 |
| AQR Arbitrage LLC | 5,843,849 | 84.5M $ | as of Mar 31, 2026 |
| SOROS FUND MANAGEMENT LLC | 5,753,186 | 83.2M $ | as of Mar 31, 2026 |
| Kryger Capital LLC | 4,554,174 | 65.9M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 4,316,272 | 61.5M $ | as of Mar 31, 2026 |
| CITIGROUP INC | 4,226,882 | 61.1M $ | as of Mar 31, 2026 |
| Magnetar Financial LLC | 3,986,058 | 57.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 3,899,490 | 56.4M $ | as of Mar 31, 2026 |
| Weiss Asset Management LP | 3,872,902 | 56M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,827,513 | 55.3M $ | as of Mar 31, 2026 |
| TIG Advisors, LLC | 3,825,445 | 55.3M $ | as of Mar 31, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3,643,352 | 52.7M $ | as of Mar 31, 2026 |
Declared shareholders of Amicus Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. and 1 other | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Amicus Therapeutics Inc". https://titelia.com/en/stocks/amicus-therapeutics-inc-US03152W1099